🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Valeant to release 4th-qtr results on March 15

Published 2016-03-07, 08:21 a/m
© Reuters.  Valeant to release 4th-qtr results on March 15
PSON
-
BHC
-

March 7 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO VRX.N said it would release preliminary
fourth-quarter results on March 15, followed by a conference
call on the same day.
The Canadian drugmaker, in an announcement last week that
Chief Executive Michael Pearson (LON:PSON) would return from medical leave,
said it would also delay releasing its results, which had been
scheduled for Feb. 29.
"February 29th was my first day back to work following a
two-month medical absence," Pearson said in a statement on
Monday. "Now that I have returned, I have been working
diligently to review the business so that I can share our latest
performance and outlook with shareholders."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.